[
  {
    "ts": null,
    "headline": "Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars",
    "summary": "It's another reason to invest in this exciting medical device stock.",
    "url": "https://finnhub.io/api/news?id=9dff4341d3021a11696ddade051b7e0aac303704b59de12c2cf7f9436575747d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772030100,
      "headline": "Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars",
      "id": 139210861,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "It's another reason to invest in this exciting medical device stock.",
      "url": "https://finnhub.io/api/news?id=9dff4341d3021a11696ddade051b7e0aac303704b59de12c2cf7f9436575747d"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom Announces Upcoming Conference Presentation",
    "summary": "SAN DIEGO, February 25, 2026--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 47th Annual Raymond James Institutional Investors Conference on Monday, March 2, 2026.",
    "url": "https://finnhub.io/api/news?id=c85d8469f9be203905568ce4d5bcff564ef29ab9e65363fbedd296d8d3898838",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772026200,
      "headline": "Dexcom Announces Upcoming Conference Presentation",
      "id": 139207770,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "SAN DIEGO, February 25, 2026--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 47th Annual Raymond James Institutional Investors Conference on Monday, March 2, 2026.",
      "url": "https://finnhub.io/api/news?id=c85d8469f9be203905568ce4d5bcff564ef29ab9e65363fbedd296d8d3898838"
    }
  },
  {
    "ts": null,
    "headline": "BTIG Reiterates Buy on DexCom, Maintains $85 Price Target",
    "summary": "BTIG  analyst Marie Thibault   reiterates DexCom (NASDAQ:DXCM) with a Buy and maintains $85 price target.",
    "url": "https://finnhub.io/api/news?id=2a77140ddf747e1be9259667b2d479199b645a7ead682a5c96ea3e727433b083",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772001567,
      "headline": "BTIG Reiterates Buy on DexCom, Maintains $85 Price Target",
      "id": 139209580,
      "image": "",
      "related": "DXCM",
      "source": "Benzinga",
      "summary": "BTIG  analyst Marie Thibault   reiterates DexCom (NASDAQ:DXCM) with a Buy and maintains $85 price target.",
      "url": "https://finnhub.io/api/news?id=2a77140ddf747e1be9259667b2d479199b645a7ead682a5c96ea3e727433b083"
    }
  },
  {
    "ts": null,
    "headline": "Mizuho Raises DexCom (DXCM) Price Target to $90 from $78 After Earnings Beat",
    "summary": "We recently published an article titled 13 Best Internet of Things (IoT) Stocks to Buy Now. On February 13, Mizuho analyst Anthony Petrone raised the price target on DexCom, Inc. (NASDAQ:DXCM) to $90 from $78 while maintaining an Outperform rating, citing a favorable post-earnings setup following a quarterly beat that exceeded expectations. The previous day, […]",
    "url": "https://finnhub.io/api/news?id=51a94261efe04bd1cf5988315672e405547faa12c8e7225c21b705f1cd9fe83e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771986566,
      "headline": "Mizuho Raises DexCom (DXCM) Price Target to $90 from $78 After Earnings Beat",
      "id": 139203886,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "We recently published an article titled 13 Best Internet of Things (IoT) Stocks to Buy Now. On February 13, Mizuho analyst Anthony Petrone raised the price target on DexCom, Inc. (NASDAQ:DXCM) to $90 from $78 while maintaining an Outperform rating, citing a favorable post-earnings setup following a quarterly beat that exceeded expectations. The previous day, […]",
      "url": "https://finnhub.io/api/news?id=51a94261efe04bd1cf5988315672e405547faa12c8e7225c21b705f1cd9fe83e"
    }
  }
]